Trial Profile
Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529 From an Extended-Release Formulation of BMS-663068 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Aug 2017
Price :
$35
*
At a glance
- Drugs Fostemsavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 02 Sep 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to completed.
- 20 Jun 2014 New trial record